Adagrasib, an Antineoplastic Drug, New Molecule in Pharma Adagrasib (Brand Name: Krazati, by Mirati Therapeutics, Inc.) is an antineoplastic drug approved by the U.S. Food and […]
Teplizumab: New Molecule in Pharma, Prevention of Type-1 Diabetes Teplizumab could be a significant development in diabetes treatment, as it could potentially delay the onset of […]